Table 2. Compound properties and measurement details.

Compound	Watersolubilitya,b[g/L]	logPow b	KOC[L/kg]	pKa b	Excretionratec [%]	PECd[µg/L]	PrecursorIon [m/z]	DaughterIons [m/z]	CollisionEnergy [eV]
ciprofloxacin	0.5	1.63	3487e	6.4;8.7	20.0	0.30	332.09	245.06	24
								288.11	17
enrofloxacin	0.1	2.31	2179e	6.4;7.8	n.a.g	n.a.g	360.12	245.06	26
								316.16	18
sulfamethoxazole	2.8	0.66	219f	5.8;1.4	30.0	1.96	254.02	108.03	23
								155.97	15
trimethoprim	1.0	0.59	301f	7.0	80	1.05	291.10	123.06	32
								230.09	23
clarithromycin	460.0	2.81	64.4b	13.1;8.2	25.0	0.09	748.43	158.00	28
								590.23	18
carbamazepine	0.2	1.90	363f	13.9	3.0	0.03	237.08	179.08	34
								194.10	20
naproxen	15.0	2.88	302f	4.8	5.5	0.43	231.08	170.08	26
								185.10	12
diclofenac	2.3	4.55	245f	4.2	5.5	0.06	296.00	214.02	35
								250.02	13
bezafibrate	140.0	2.50	398f	3.3	50.0	0.10	362.08	121.06	29
								138.97	26

^aat pH 7 and 25°C;

^bData are from SciFinder Database (https://scifinder.cas.org), accessed May 2, 2012;

^cData are from Verlicchi et al. [74];

^dPredicted Environmental Concentration (including excretion rate, mean 2003/2004);

^eData are from Figuero-Diva et al. [75];

^fData are from Barron et al. [76];

^gnot available.